Internship

Software Engineering Summer Analyst

Testing Pipeline

Posted on 1/6/2025

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

Compensation Overview

$25/hr

+ Relocation Bonus

No H1B Sponsorship

Chicago, IL, USA

Hybrid internship requiring 3 days in-office per week.

Category
Software QA & Testing
Finance & Banking
Software Engineering
Required Skills
JavaScript
React.js
MySQL
Postgres
TypeScript
HTML/CSS
Requirements
  • Pursuing a Bachelor's degree (undergraduate completion in summer of 2026)
  • Computer Science / Computer Engineering
  • GPA: 3.0+
  • Object Oriented Programming Experience. Javascript / Typescript a bonus.
  • HTML & CSS
  • Relational Database Experience (MySQL / PostgreSQL / etc…)
  • Experience with ReactJS a bonus
  • Excellent written and verbal communication skills in a variety of settings and media.
  • Strong computer skills, including advanced knowledge of Google Suite and Gmail, preferred.
  • A self-starter with the ability to work independently as well as in collaboration with others in a fast-paced environment is critical. Be ready to fly the plane as you’re still building it!
Responsibilities
  • Apply skills and knowledge learned in the classroom to on-the-job experiences
  • Work on comprehensive, value-added project(s) that help enhance the fields of science and technology
  • Collaborate with teams/colleagues in a fast-paced environment
  • Gain professional development & build relationships with peers from across the country
  • Creating and improving our Admin manager tooling used by our engineering and laboratory management teams
  • Working on quality of life improvements and features requested by the laboratory users
  • Contributing to our build pipeline to ensure safe deployments
Desired Qualifications
  • Javascript / Typescript a bonus
  • Experience with ReactJS a bonus
  • Strong computer skills, including advanced knowledge of Google Suite and Gmail, preferred

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data, helping physicians make informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Deep 6 AI expands Tempus' data network and precision medicine capabilities.
  • $560 million debt financing supports Tempus' growth and AI-driven healthcare solutions.
  • Collaboration with Artera enhances AI cancer test access, increasing Tempus' oncology influence.

What critics are saying

  • Integration challenges with Deep 6 AI could delay Tempus' expansion plans.
  • $560 million debt financing increases financial leverage, posing risk if revenue growth lags.
  • Exclusive partnership with Artera may limit Tempus' collaboration opportunities in prostate testing.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus' pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Life Care News
Mar 30th, 2025
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Tempus exhibits 4 abstracts at the 2025 American College of Cardiology Annual Meeting.

Tempus
Mar 12th, 2025
Tempus Announces Acquisition of Deep 6 AI | Tempus AI

Deep 6 is integrated with over 750 provider site locations spanning more than 30 million patients, which will materially add to Tempus’ existing network CHICAGO --(BUSINESS WIRE)--Mar. 11, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision

TipRanks
Mar 12th, 2025
Tempus AI (TEM) Strengthens Precision Medicine with Deep 6 AI Deal, Cathie Wood Buys the Dip

Tempus AI has acquired Deep 6 AI to expand its reach and enhance offerings in precision medicine.

Business Wire
Feb 25th, 2025
Ares Management Upsizes Tempus Debt Facilities to $560 Million

Combined with $260 million of capital provided in 2022 and 2023, Ares Credit funds have provided Tempus a total debt package of approximately $560 million.

Pulse 2.0
Feb 24th, 2025
Tempus Secures $560M Debt Financing

Ares Management announced that Ares Credit funds provided $300 million in additional debt financing to Tempus AI, bringing the total debt package to $560 million. This financing supports Tempus' acquisition of Ambry Genetics, completed on February 3, 2025. Ares praised Tempus' growth strategy and AI-enabled solutions in medicine. Tempus' CFO, Jim Rogers, expressed appreciation for Ares' investment, which aids in enhancing healthcare technology and patient outcomes.

INACTIVE